Ivermectin – The Miracle Drug Not What The Media Says

Ivermectin – The Miracle Drug Not What The Media Says

What is Ivermectin?

ivermectin the miracle drug

From what you read in the media, you would think Ivermectin is the worst drug ever.  Did you know that it won a Nobel Prize?  So, when you think of a miracle drug, you think of something that has prevented millions of potentially fatal and debilitating infectious diseases from infecting people worldwide. It is a highly effective drug that is widely available and relatively inexpensive.  This is the real description of Ivermectin and numerous studies have proven it’s effectiveness, you just have to dig in closer like we did.

It prevents millions of potentially fatal and debilitating infectious diseases

If you look at the history of ivermectin, you’ll find that it has made an incredible impact on the world. From its early days in veterinary medicine, to its current use for treatment of several infectious diseases, the miracle drug has had a remarkable effect on mankind. Hundreds of millions of people in poor countries are now protected against disease thanks to its widespread use.

The discovery of ivermectin involved a large number of factors, including education, a dedication to the cause, and pioneering public sector-private sector partnership. It also benefited from the input of many researchers, both at Merck and in Africa.

In the mid-1970s, a group of researchers at the Kitasato Institute in Tokyo developed a fermentation broth that contained a microorganism known as avermectin. They tested the compound on backyard chickens. When they found the broth had a strong bioactivity, they sent it to Merck. Afterwards, researchers at Merck began working on refining the compound into an ivermectin derivative.

By the late 1970s, this miracle drug was used in human health. A single dose of the drug triggered a dramatic reduction in the number of dermal microfilariae, a type of worm that causes scabies. Over the course of six years, ivermectin dramatically reduced the number of scabies cases, as well as the severity of cases.

Ivermectin became a key component in the treatment of lymphatic filariasis and onchocerciasis. Several other neglected tropical diseases were also combated with the drug. These include trachoma and yaws. Now, ivermectin is the only tool available to treat these diseases in 16 African nations.

As more and more resistance develops to the currently available agents, interest is growing in developing a vaccine or other novel therapeutic agents to treat scabies. Meanwhile, the drug is being hailed as a “wonder drug” for preventing millions of potentially fatal and debilitating infectious diseases.

It may be useful against COVID-19

Ivermectin is an anti-parasitic drug that has been used to treat parasitic infections in both humans and animals. The drug has been used in Africa for decades to stop and prevent Malaria.

While it was discovered in the mid-1970s, and it is considered a broad-spectrum agent today, the media is trying to show the worst possible side of this miracle drug. It is also an anti-helminth agent. However, it is not approved to treat COVID-19 per the CDC. Several studies have looked at the drug as a possible treatment for the virus, and the results have been overwhelmingly positive when it is used as a prophylaxis.

There is some evidence that it may be useful for COVID-19 when given early on. This is based on a study that looked at the effects of ivermectin on viral shedding, which has been reported as a key symptom of the disease. In addition, the study found that it reduced the inflammatory response to the COVID-19 virus.

Although the benefits of ivermectin are not clear, it is believed to be one of the safest drugs in the world. However, just like nearly every drug on the market, there have been reports of side effects. These include seizures, hallucinations, and decreased consciousness. Fortunately, it is generally well tolerated and is known to be safer than Tylenol.

Despite these findings, the National Institutes of Health’s COVID-19 Treatment Guidelines Panel found that there is not sufficient evidence to recommend ivermectin for the treatment of COVID-19. They suggested that data from well-designed clinical trials are required to prove the effectiveness of the drug.  Despite their recommendations, numerous studies are available on the NIH website showing that they made a mistake and should revisit their decision.

The panel reviewed several other studies to determine whether the data had merit. Several of the studies did not have strong methodological strengths. Many of them were not published, and some have been retracted. A number of the trials had short durations. Most of the trials were not powered to determine the impact of ivermectin on secondary outcomes.

It is widely available and relatively cheap

Ivermectin is a relatively inexpensive drug used to treat many different diseases. It is a potent anti-parasitic and has been approved for use in humans and animals. However, there are some potential safety risks with its use. Some of these include nausea, vomiting, diarrhea, and overdose which are pretty common side effects in almost every drug.

While ivermectin has been used to treat a variety of human and animal diseases, there is no evidence to support its use as a treatment for COVID-19. However, numerous studies have concluded that when used as a prophylaxis, it has been very successful in over 90% of subjects.

As an anti-parasitic, ivermectin is known to limit infection by RNA viruses. In addition, it is known to inhibit the growth of a tumor cell called PRV, and may also be effective in limiting the spread of West Nile Virus. Several studies have also suggested that ivermectin may be effective in treating SARS-CoV-2, the virus causing COVID-19 when used prophylactically.

The drug has also been found to increase survival rates in mice infected with PRV. Moreover, the drug is known to limit the reproduction of the SARS-CoV-2 virus.

Ivermectin is also considered to be a promising anti-cancer agent. Researchers are also looking into developing a new delivery system for ivermectin. This might involve skin patches or slow-release formulations. A recent study by Gordon et al. reports that ivermectin may have the ability to block the nuclear transport of the SARS-CoV-2.

Although ivermectin is not yet approved for use as a treatment for COVID-19 in people, there are still a number of clinical trials underway to examine its effectiveness. If ivermectin is proved to be safe and effective, it will likely be an important addition to the global response to the virus.

Currently, ivermectin is available in the form of Mectizan. However, there are many other forms of the drug, including stromectol.

It keeps SARS-CoV-2 from replicating in cell cultures

Ivermectin has been widely studied in the context of human immunodeficiency virus (HIV). However, ivermectin is also used to treat genital warts and it has been shown to be effective against several flaviviruses. It is believed that ivermectin inhibits several processes involved in the infection of both RNA and viral proteins.

In vitro studies have demonstrated that ivermectin is an effective SARS-CoV-2 inhibitor. The compound inhibited SARS-CoV-2 replication in human pulmonary cell cultures. Moreover, it has been shown that it may prevent nuclear import of SARS-CoV-2. This was further confirmed by thermal denaturation analysis.

In addition, IVM was found to have significant inhibitory activity against the WNV helicase. The IC50 value was in the sub-nanomolar range. Moreover, the ATPase activity of the helicase domain was not affected.

In addition, the study showed that both avermectins and milbemycins effectively blocked infection of Calu-3 cells with SARS-CoV-2. These compounds also showed inhibitory activity against YFV-17D.

Lastly, the results showed that the EC50 values of ivermectin and MOX were in the sub-nanomolar range. However, the EC50 of MIL was lower. Interestingly, the selectivity of avermectins was higher than that of milbemycins. Consequently, avermectins were more effective than milbemycins in protecting against SARS-CoV-2.

Ivermectin is a macrocyclic lactone that belongs to a group of compounds called avermectins. They are synthesized through a semi-fermentation pathway. Each compound differs from one another by position 13 in the macrolide ring.

Previously, avermectins have been shown to protect against infection of Vero E6 cell lines with SARS-CoV-2. Moreover, they also blocked infection of A549-hACE2 cells with SARS-CoV-2.

Moreover, IVM/MOX also interfered with viral replication complexes. Furthermore, SARS-CoV-2 MOX/IVM treated cells had reduced S-dependent syncytia formation.

It is a wonder drug before it became a household name

Ivermectin is a chemical compound, which has an anti-parasitic effect. It has been widely used to treat a number of different parasitic diseases. These diseases include leishmaniasis, which is common in tropical countries, and strongyloidiasis, which is a bacterial disease that affects between 30 and 100 million people around the world.

Ivermectin has been a highly effective medication for millions of patients. However, the recent popularity of this drug has caused some serious concerns for those who take it. The drug is often promoted by popular figures, such as Joe Rogan, who admits that taking ivermectin prophylactically will helped him treat COVID-19.

Despite the many benefits, however, ivermectin can also cause serious harm to people when used incorrectly. There have been reports of overdoses, as well as poison control calls. Although the drug has been approved for use in domestic pets, it is not safe for livestock. If you are pregnant or breast-feeding, please tell your health care provider.

Some of the most popular uses for ivermectin are in the prevention and treatment of genital warts, sex drive, high blood pressure, and heartworm disease. As more studies are conducted, additional uses for the drug are being identified.

A group of doctors and health care professionals are calling for more widespread use of ivermectin. They believe it is an underused public health strategy. Since it is a broad-spectrum antibiotic, it has the potential to help prevent a variety of diseases.

The demand for ivermectin in Canada has been high since last year. It has become available for over the counter use in Tennessee in the United States. This shortage could put those who need it at risk.

While the drug has been proven to be effective in treating a wide range of parasitic infections, it does not have the same antiviral effect as other medications. Researchers have found evidence that ivermectin can inhibit the replication of a new coronavirus in human cells. In fact, this discovery led to the award of a half of the 2015 Nobel Prize in Physiology or Medicine.

If you like what you read, check out our other health articles here.


Check out our monthly newsletter and subscribe to your topics!

Subscribe to our Newsletter

Ready to get started, Get our Newsletter and join the Community!

More Articles & News

Other articles that may be of interest